'Ben Greenfield\'s \"Day Two\" Microbiome Test results'

$'Ben Greenfield\'s \"Day Two\" Microbiome Test results'$

12:04 Jun 10, 2021 1 1

'DayTwo is the leading Microbiome-Based Precision Medicine company, developing personalized nutrition, diagnostic, and therapeutic solutions using artificial intelligence and machine learning on microbial genomics, human traits, and disease.  DayTwo’s initial product enables glycemic control. The ML technology that powers the glycemic control product was first demonstrated in clinical trials 8 years ago. DayTwo’s glycemic control product is targeted for people with Type 2 Diabetes and people who want to maintain a healthy lifestyle and helps balance blood sugar levels using a “food-as-medicine” approach, personalized to DNA sequencing of the microbiome, coupled with standard biometrics and lifestyle habits.  Since we all respond differently to the same foods, we each need to choose the foods that are healthy for us. Different people have different blood sugar responses to the same foods, so it is essential to understand what your body needs – and to plan accordingly. High blood sugar is linked to energy dips, excessive hunger, weight gain and increased risk of obesity, diabetes and a host of other metabolic disorders.  Check out my results in the video above and leave your thoughts below.'

Tags: nutrition , genetic testing , genetics , apps , microbiome , machine learning , ben greenfield , gut test , microbiome test , personalized nutrition app , Day Two , gut tests , test your gut